N-(4-bromophenyl)-N-biphenylylamine

We are N-(4-bromophenyl)-N-biphenylylamine CAS:1160294-93-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-(4-bromophenyl)-N-biphenylylamine
CAS.NO:1160294-93-8
Synonyms:(biphenyl-4-yl)-(4-bromophenyl)amine
4-bromophenyl-biphenyl-4-yl-amine
Molecular Formula:C18H14BrN
Molecular Weight:324.21400
 
Physical and Chemical Properties:
Melting point:132ºC
 
Specification:
Appearance:White-yellow crystalline powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

N-(4-bromophenyl)-N-biphenylylamine


Related News: However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.azetidin-3-ona, hidrocloruro CAS:17557-84-5 As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.5-bromo-2-fluoro-3-metilpiridina CAS:29312-98-9 As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.Isopropyl isocyanate Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.

Related Products
Product Name
3-Chloromethyl-benzotrifluoride View Details
sodium,2-chloro-2,2-difluoroacetate View Details
3,5-Difluoroaniline View Details
benzyl (4S)-2,5-dioxo-4-propan-2-yl-1,3-oxazolidine-3-carboxylate manufacturer 2-Bromo-6-Methyl-3-Nitropyridine manufacturer N-Sulphamyl-3-chloropropionamidine hydrochloride manufacturer 3-(4-chlorophenyl)pentanedioic acid manufacturer 4-nitroheptanedial manufacturer